ASND ▲ +0.4% - Ascendis Pharma A/S $ASND - Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide) Ascendis Pharma rose 0.4% following news that the company and BioMarin have entered into a binding term sheet for a global settlement and license agreement related to YUVIWEL® (navepegritide). The settlement appears to resolve a dispute between the two companies while establishing a licensing arrangement for the growth hormone treatment, which likely reduces legal uncertainty for Ascendis. 31-AUG-2026 07:00 AM ET